As our research uncovers more subtypes and personalised treatments, clear communication about biomarkers with patients is increasingly crucial. Our global survey with ABC Global Alliance emphasises the need to empower people living with metastatic breast cancer with knowledge about biomarkers to engage in their care decisions. To learn more visit: https://learn.az/6048gBOaY
Clear communication and empowering patients with knowledge about biomarkers are essential in ensuring informed care decisions for those living with metastatic breast cancer. With deeper data and insights, PointClickCare Life Sciences biomarker counts could contribute to the advancement of personalized treatments in oncology.
This is something that is very worthy of attention for women.
Empowering patients with knowledge about biomarkers is key to personalized care decisions. This initiative is pivotal in improving outcomes for those with metastatic breast cancer. #PatientEmpowerment
Great for sharing and educating people with this disease.
Dear AstraZeneca Team, We are excited to invite your esteemed organization to apply for the prestigious EUTECH SDG Awards. Your remarkable achievements in sustainability and contributions towards the Sustainable Development Goals have not gone unnoticed. This is a fantastic opportunity to gain recognition for your innovative efforts and to showcase your commitment to a sustainable future on a global platform. We believe your contributions are exemplary and would make a significant impact in this competition. To apply or learn more about the EUTECH SDG Awards, please visit our website: https://sdgawards.eutech.org/ We look forward to your participation and celebrating your continued success in sustainability. Warm regards, EUTECH SDG Awards Team